Table 1 Clinical characteristics No. .... | American Society of Hematology

Table 1

Clinical characteristics

No.	Diagnosis	Age, y	Sex	Skin lesions at diagnosis	Extracutaneous disease	Initial treatment	Result	Relapse, mo	Sites of relapse	Follow-up, mo
1	CD4⁺CD56⁺HN	67	F	Generalized plaques and tumors	Tumors in both breasts	Chemotherapy	PD	—	—	DOD, 7
2	CD4⁺CD56⁺HN	74	M	Generalized plaques and nodules	—	Chemotherapy	CR	10	Skin, BM	DOD, 12
3	CD4⁺CD56⁺HN	60	M	Solitary tumor scalp	—	Radiotherapy	CR	13	Skin, BM, LN, blood	DOD, 22
4	CD4⁺CD56⁺HN	56	M	Plaques and tumors on trunk and head	BM	Chemotherapy	CR	9	Skin, BM, CNS	DOD, 29
5	CD4⁺CD56⁺HN	7	M	Solitary tumor on left arm	—	Chemotherapy	CR	—	—	CR, 20
6	c-AML	94	F	Large tumorous mass on trunk	—	Radiotherapy	CR	7	Skin, blood	DOD, 12
7	c-AML	65	M	Generalized plaques and tumors	—*	Radiotherapy	PD	3	BM, blood	DOD, 4
8	c-AML	83	M	Plaques on right hand and left leg	—	None	—	2	BM, blood	DOD, 5
9	c-AML	72	M	Plaques on back and chest	BM, blood	Chemotherapy	PD	—	—	DOD, 1
10	c-AML	65	M	Generalized nodules and tumors	BM, blood, CNS, testis	Chemotherapy	PD	—	—	DOD, 6
11	c-AML	2	M	Solitary tumor scalp	MDS	Chemotherapy	CR	—	—	CR, 37

No.	Diagnosis	Age, y	Sex	Skin lesions at diagnosis	Extracutaneous disease	Initial treatment	Result	Relapse, mo	Sites of relapse	Follow-up, mo
1	CD4⁺CD56⁺HN	67	F	Generalized plaques and tumors	Tumors in both breasts	Chemotherapy	PD	—	—	DOD, 7
2	CD4⁺CD56⁺HN	74	M	Generalized plaques and nodules	—	Chemotherapy	CR	10	Skin, BM	DOD, 12
3	CD4⁺CD56⁺HN	60	M	Solitary tumor scalp	—	Radiotherapy	CR	13	Skin, BM, LN, blood	DOD, 22
4	CD4⁺CD56⁺HN	56	M	Plaques and tumors on trunk and head	BM	Chemotherapy	CR	9	Skin, BM, CNS	DOD, 29
5	CD4⁺CD56⁺HN	7	M	Solitary tumor on left arm	—	Chemotherapy	CR	—	—	CR, 20
6	c-AML	94	F	Large tumorous mass on trunk	—	Radiotherapy	CR	7	Skin, blood	DOD, 12
7	c-AML	65	M	Generalized plaques and tumors	—*	Radiotherapy	PD	3	BM, blood	DOD, 4
8	c-AML	83	M	Plaques on right hand and left leg	—	None	—	2	BM, blood	DOD, 5
9	c-AML	72	M	Plaques on back and chest	BM, blood	Chemotherapy	PD	—	—	DOD, 1
10	c-AML	65	M	Generalized nodules and tumors	BM, blood, CNS, testis	Chemotherapy	PD	—	—	DOD, 6
11	c-AML	2	M	Solitary tumor scalp	MDS	Chemotherapy	CR	—	—	CR, 37

PD indicates progressive disease; DOD, died of disease; CR, complete remission; BM, bone marrow; LN, lymph nodes; CNS, central nervous system; MDS, myelodysplastic syndrome; and —, not applicable.

AML (M2) in bone marrow 9 months before development of skin lesions; after chemotherapy, relapse with only skin lesions.

View Large

This Feature Is Available To Subscribers Only